Gene therapy for hearing loss caused by TOMT mutations
Official title: Cell type-specific gene therapy approach for TOMT-linked congenital hearing loss
Funded at Echogenesis Therapeutics INC · NIH-11066259 · Data updated 2026-11-12
This study is working on a new gene therapy to help people with congenital hearing loss caused by TOMT mutations, aiming to create a treatment that directly targets the right cells in the ear to improve hearing with fewer side effects.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Echogenesis Therapeutics INC NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | January 6, 2025 |
| Project end | December 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $305,628 |
| NIH project number | 1R41DC022471-01 |
| Project ID | NIH-11066259 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with congenital hearing loss due to TOMT mutations.
✕Less likely to help
Patients with hearing loss not linked to TOMT mutations or those with other unrelated forms of hearing impairment may not benefit from this research.
What this research studies
This research focuses on developing a targeted gene therapy for congenital hearing loss linked to TOMT mutations. By utilizing a precision medicine approach, the team aims to create therapies that specifically target the affected cell types in the cochlea, minimizing side effects and maximizing therapeutic benefits. The methodology involves computational screening and in vivo testing to identify specific genomic promoter fragments that can effectively express therapeutic genes in cochlear hair cells. This innovative approach seeks to address the limitations of current gene therapies that do not adequately restore hearing.
Why it matters
Potential benefit: If successful, this research could lead to effective gene therapies that restore hearing in patients with TOMT-linked congenital hearing loss.
How similar studies have gone: Previous research using adeno-associated viral gene therapies for other forms of genetic hearing loss has shown promise, indicating potential for success with this novel approach.
Where this research is happening
-
Echogenesis Therapeutics INC
Pittsburgh, United States Active
Researchers
- Principal investigator: Cunningham, Christopher L — Echogenesis Therapeutics INC
- Study coordinator: Cunningham, Christopher L
Related research
Other NIH-funded projects on the same topics.
-
Noise-related hearing loss and its link to Alzheimer's progression
Researchers are looking at whether hearing damage from loud noise speeds memory loss and dementia in people at risk for Alzheimer's.
-
Audiological rehabilitation for children with unilateral hearing loss
A research project aims to help children who hear with one ear by testing ways to improve their hearing and communication through targeted audiology interventions.
-
Choosing the right hearing device for kids with moderate-to-severe hearing loss
This grant explores which hearing device—hearing aids or cochlear implants—works best for children aged 0-11 with moderate-to-severe hearing loss.
-
Noise-related hearing loss and brain-to-ear feedback in hearing protection
A small, patient-friendly study will look at how loud noise changes the brain’s control over hearing and whether this affects conditions like tinnitus or sensitivity to sound.
-
How loud noise can change the brain's sound decisions
This project looks at how loud noise-related hearing loss may affect how people process sounds and make quick decisions about what they hear.
-
Understanding how tactile language and wearable tech can help DeafBlind children learn and use language
A study at Gallaudet University tests a new tactile language and wearable haptic devices to help DeafBlind children build early language and everyday life skills.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.